Method for the synthesis of highly pure vaccines using the lipid core peptide system

Journal of Peptide Science

Volumn 12, Issue 12, 2006, Pages 800-807

  Moyle, Peter M ^a   Olive, Colleen ^b   Good, Michael F ^b   Toth, Istvan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Adjuvants; Group A streptococcus; Lipid core peptide; Lipoamino acids; Lipopeptides; Native chemical ligation; Sodium dodecyl sulfate; Vaccine development

Indexed keywords

ADJUVANT; BACTERIAL PROTEIN; CORE PROTEIN; DODECYL SULFATE SODIUM; EPITOPE; IMMUNOGLOBULIN G; STREPTOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CHEMICAL REACTION; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNIZATION; IMMUNOGENICITY; LIPOPHILICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; EPITOPES; FEMALE; IMMUNOGLOBULIN G; LIPIDS; MICE; MOLECULAR STRUCTURE; PEPTIDES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; VACCINES, SYNTHETIC;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 33845616320     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.815     Document Type: Article

References (40)

1. Davey S. In State of the World's Vaccines and Immunization, Geyer M (ed.). World Health Organization: Geneva, 2003.
2. Babiuk LA. Broadening the approaches to developing more effective vaccines. Vaccine 1999; 17: 1587-1595.
3. Wiesmuller KH, Fleckenstein B, Jung G. Peptide vaccines and peptide libraries. Biol. Chem. 2001; 382: 571-579.
4. BenMohamed L, Wechsler SL, Nesburn AB. Lipopeptide vaccines-yesterday, today, and tomorrow. Lancet Infect. Dis. 2002; 2: 425-431.
5. Gras-Masse H. Single-chain lipopeptide vaccines for the induction of virus-specific cytotoxic T cell responses in randomly selected populations. Mol. Immunol. 2001; 38: 423-431.
6. Jung G, Wiesmüller KH, Becker G, Bühring H-J, Bessler WG. Increased production of specific antibodies by presentation of the antigen determinants with covalently coupled lipopeptide mitogens. Angew. Chem., Int. Ed. Engl. 1985; 24: 872-873.
7. Gahéry-Ségard H, Pialoux G, Charmeteau B, Sermet S, Poncelet H, Raux M, Tartar A, Lévy JP, Gras-Masse H, Guillet J-G. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J. Virol. 2000; 74: 1694-1703.
8. Moyle PM, McGeary RP, Blanchfield JT, Toth I. Mucosal immunisation: adjuvants and delivery systems. Curr. Drug Discov. 2004; 1: 385-396.
9. Olive C, Batzloff MR, Horváth A, Wong A, Clair T, Yarwood P, Toth I, Good MF. A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect. Immun. 2002; 70: 2734-2738.
10. Horváth A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group A streptococcal peptide epitopes. J. Med. Chem. 2002; 45: 1387-1390.
11. Horváth A, Olive C, Wong A, Clair T, Yarwood P, Good M, Toth I. A lipophilic adjuvant carrier system for antigenic peptides. Lett. Pept. Sci. 2002; 8: 285-288.
12. Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect. Immun. 2003; 71: 2373-2383.
13. Moyle PM, Horváth A, Olive C, Good MF, Toth I. Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection. Lett. Pept. Sci. 2004; 10: 605-613.
14. Olive C, Batzloff M, Horváth A, Clair T, Yarwood P, Toth I, Good MF. Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. Indian J. Med. Res. 2004; 119: 88-94.
15. Horváth A, Olive C, Karpati L, Sun HK, Good M, Toth I. Toward the development of a synthetic group A streptococcal vaccine of high purity and broad protective coverage. J. Med. Chem. 2004; 47: 4100-4104.
16. Olive C, Hsien K, Horvath A, Clair T, Yarwood P, Toth I, Good MF. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Vaccine 2005; 23: 2298-2303.
17. Toth I, Danton M, Flinn N, Gibbons WA. A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilizing lipidic amino acids. Tetrahedron Lett. 1993; 34: 3925-3928.
18. Gibbons WA, Hughes RA, Charalambous M, Christodoulou M, Szeto A, Aulabaugh AE, Mascagni P, Toth I. Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers. Liebigs Ann. Chem. 1990; 1175-1183.
19. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 5409-5413.
20. Schild H, Rammensee H-G. Peptide based vaccines. In Concepts in Vaccine Development, Kaufmann SHE (ed.). Berlin, 1996; 303-325.
21. + IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery. J. Immunol. 2002; 168: 6189-6198.
22. Jackson DC, O'Brien-Simpson N, Ede NJ, Brown LE. Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine 1997; 15: 1697-1705.
23. Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat. Med. 2000; 6: 455-459.
24. Dakappagari NK, Pyles J, Parihar R, Carson WE, Young DC, Kaumaya PT. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses. J. Immunol. 2003; 170: 4242-4253.
25. Livingston BD, Newman M, Crimi C, McKinney D, Chesnut R, Sette A. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 2001; 19: 4652-4660.
26. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect. Inunun. 2002; 70: 2171-2177.
27. Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int. Immunol. 1997; 9: 1723-1733.
28. Hartas J, Goodfellow AM, Currie BJ, Sriprakash KS. Characterisation of group A streptococcal isolates from tropical Australia with high prevalence of rheumatic fever: probing for signature sequences to identify members of the family of serotype 5. Microb. Pathog. 1995; 18: 345-354.
29. Schnölzer M, Alewood P, Jones A, Alewood D, Kent SBH. In situ neutralization in Boc-chemistry solid phase peptide synthesis. Int. J. Pept. Protein Res. 1992; 40: 180-193.
30. Hackeng TM, Griffin JH, Dawson PE. Protein synthesis by native chemical ligation: expanded scope by using straightforward methodology. Proc. Natl. Acad. Sci. U.S.A. 1999; 96: 10068-10073.
31. Sarin V, Kent SBH, Tam JP, Merrifield B. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal. Biochem. 1981; 117: 147-157.
32. Christensen T. A qualitative test for monitoring coupling completeness in solid phase peptide synthesis using chloranil. Acta Chem. Scand. B 1979; B33: 763-766.
33. Vojkovsky T. Detection of secondary amines on solid phase. Pept. Res. 1995; 8: 236-237.
34. Li X, Kawakami T, Aimoto S. Direct preparation of peptide thioesters using a Fmoc solid-phase method. Tetrahedron Lett. 1998; 39: 8669-8672.
35. Pruksakorn S, Galbraith A, Houghten RA, Good MF. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J. Immunol. 1992; 149: 2729-2735.
36. Dawson PE, Muir TW, Clark-Lewis I, Kent SBH. Synthesis of proteins by native chemical ligation. Science 1994; 266: 776-779.
37. Deshpande A, Nimsadkar S, Mande SC. Effect of alcohols on protein hydration: crystallographic analysis of hen egg-white lysozyme in the presence of alcohols. Acta Crystallogr. 2005; D61: 1005-1008.
38. Calandrini V, Fioretto D, Onori G, Santucci A. Role of hydrophobic interactions on the stabilisation of native state of globular proteins. Chem. Phys. Lett. 2000; 324: 344-348.
39. Halle B. Protein hydration dynamics in solution: a critical survey. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 2004; 359: 1207-1224.
40. Vahyaveetil FI, MacKinnon R, Muir TW. Semisynthesis and folding of the potassium channel KcsA. J. Am. Chem. Soc. 2002; 124: 9113-9120.